Development of gamma delta (gd) T-cell immunotherapy for triple negative breast cancer (TNBC)

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/201431/01/2017

Collaborative partners

Funding

  • CRUK Cancer Research UK: £81,240.00
  • CRUK Cancer Research UK: £127,752.00